HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA commissioner confirmation vote for Henney not likely before the week of Sept. 14.

This article was originally published in The Rose Sheet

Executive Summary

FDA COMMISSIONER CONFIRMATION VOTE NOT EXPECTED BEFORE WEEK OF SEPT. 14, following the confirmation hearing for University of New Mexico VP-Health Sciences Jane Henney, MD, held by the Senate Labor & Human Resources Committee Sept. 2. Following the hearing, committee Chairman James Jeffords (R-Vt.) will gather follow-up questions from committee members and forward them to Henney for responses. The Administration's choice for FDA commissioner replied to a 140-item pre-hearing questionnaire Aug. 24 ("The Rose Sheet" Aug. 31, In Brief).



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts